Stocks and Investing Stocks and Investing
Fri, January 26, 2018
Thu, January 25, 2018

Tazeen Ahmad Maintained (ASND) at Strong Buy with Increased Target to $60 on, Jan 25th, 2018


Published on 2024-10-26 02:13:42 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Increased Target from $45 to $60 on, Jan 25th, 2018.

Tazeen, nor any peers, have made any analyst calls on ASND in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources